Solid Biosciences (SLDB) Capital Leases (2018 - 2024)
Solid Biosciences (SLDB) recorded Capital Leases of $307,000 in Q3 2024, down 77.5% from $1.36 million a year earlier and down 67.8% from the prior quarter.
Powered by 
Analysis
Solid Biosciences (SLDB) Capital Leases (2018 - 2024) Analysis & Trends
At the end of FY2023, Solid Biosciences reported Capital Leases of $1.23 million, down 27.5% from FY2022.
- Annual Capital Leases has a five-year compound annual growth rate of 7.5% (FY2018 to FY2023).
- Across earlier years, Capital Leases came in at $1.7 million in FY2022 (+481.2%), $293,000 in FY2021 (-44.2%), $525,000 in FY2020 (-28.4%) and $733,000 in FY2019 (-14.7%).
- The Q3 2024 figure is the lowest quarterly Capital Leases since Q1 2022.
- On a year-over-year basis, Capital Leases has declined for four consecutive quarters, with growth averaging 150.1% over the last six quarters.
- Peak year-over-year performance for Capital Leases in the last five years was growth of 590.9% in Q1 2023, against a decline of 77.5% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $953,000 (Q2 2024), $1.1 million (Q1 2024) and $1.23 million (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.02 Bn | 1,100.60 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.16 Bn | 531.69 Bn | 17.26 Bn |
| 3 | AbbVie | 503.74 Bn | 476.85 Bn | 12.70 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.66 Bn | 261.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.30 Bn | 234.99 Bn | 12.86 Bn |
| 7 | Amgen | 236.04 Bn | 191.44 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.96 Bn | 165.16 Bn | 6.22 Bn |
| 9 | Pfizer | 169.89 Bn | 116.53 Bn | 10.94 Bn |
| 10 | Solid Biosciences | 926.07 Mn | -256.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 307,000.00 |
| Jun 30, 2024 | 953,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Mar 31, 2022 | 231,000.00 |
| Dec 31, 2021 | 293,000.00 |
| Sep 30, 2021 | 353,000.00 |
| Jun 30, 2021 | 412,000.00 |
| Mar 31, 2021 | 469,000.00 |
| Dec 31, 2020 | 525,000.00 |
| Sep 30, 2020 | 579,000.00 |
| Jun 30, 2020 | 632,000.00 |
| Mar 31, 2020 | 683,000.00 |
| Dec 31, 2019 | 733,000.00 |
| Sep 30, 2019 | 782,000.00 |
| Jun 30, 2019 | 829,000.00 |
API Access
Solid Biosciences Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=SLDB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();